Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

PURPOSE: Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of early mortality (EM). In a multicenter randomized comparison against oral chemotherapy, autotransplantation was associated with 24% E...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Oncol
मुख्य लेखकों: D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2015
विषय:
ORIGINAL REPORTS
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737858/
https://ncbi.nlm.nih.gov/pubmed/26371138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.4015
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन